Security key
695127100
Pacira BioSciences, Inc. - COMMON STOCK (PCRX)
CUSIP: 695127100
Q1 2017 13F Holders as of 31 Mar 2017
- Security type / class
- Equity / COMMON STOCK
- Total 13F shares
- 40,931,045
- Total 13F value
- $1,867,446,801
- Share change
- +4,125,479
- Put/Call ratio
- 81%
- SEC-reported price per share
- $45.60
- Number of holders
- 187
- Value change
- +$210,949,898
- Number of buys
- 109
- Number of sells
- 93
- Shares outstanding
- 39,614,942
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q1 2017
Institutions
187
Top holders
10
PCRX full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q2 2026
Pacira BioSciences, Inc. SEC filings
Pacira BioSciences, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 695127100
Recent filing periods:
Ownership snapshot
Top reported holders of PCRX - Pacira BioSciences, Inc. - COMMON STOCK (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
VANGUARD GROUP INC
Disclosed value leader
VANGUARD GROUP INC
Comparable rows
15/15
Latest evidence
31 Dec 2016
13F
Lead comparable stake: 6.9%
Showing 1-6 of 15 holder rows.
Quick read
VANGUARD GROUP INC leads the comparable SEC ownership view at 6.9%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens VANGUARD GROUP INC's linked filing trail.
Comparable ownership
Top 5
VANGUARD GROUP INC
6.9%
PRICE T ROWE ASSOCIATES INC /MD/
6.5%
BlackRock Fund Advisors
4.9%
FMR LLC
4.4%
WESTFIELD CAPITAL MANAGEMENT CO LP
4%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| VANGUARD GROUP INC |
13F
Company
|
6.9%
|
$88,735,000
2,747,239 shares
|
— | 31 Dec 2016 |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
Company
|
6.5%
|
$83,318,000
2,579,501 shares
|
— | 31 Dec 2016 |
| BlackRock Fund Advisors |
13F
Company
|
4.9%
|
$62,066,000
1,921,554 shares
|
— | 31 Dec 2016 |
| FMR LLC |
13F
Company
|
4.4%
|
$56,674,000
1,754,619 shares
|
— | 31 Dec 2016 |
| WESTFIELD CAPITAL MANAGEMENT CO LP |
13F
Company
|
4%
|
$51,799,000
1,603,681 shares
|
— | 31 Dec 2016 |
| HealthCor Management, L.P. |
13F
Company
|
4%
|
$50,873,000
1,575,000 shares
|
— | 31 Dec 2016 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q1 2017
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
187
Shares
40,931,045
Rows available
187
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q1 2017 vs Q1 2017 Across Filers
Q1 2017 holders
187
Q1 2017 holders
187
Holder diff
0
| Investor | Q1 2017 Shares | Q1 2017 Shares | Share Diff | Share Chg % | Q1 2017 value | Q1 2017 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend